Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycythemia Vera 4Myeloproliferative Disorders 3Thymic aplasia 1Thrombosis 1Smoking 1Sarcoma 1Primary Dysautonomias 1Polycythemia 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Insulin Resistance 1Immunologic Deficiency Syndromes 1Hyperandrogenism 1Histiocytoma, Malignant Fibrous 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Metformin 8Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2Clomiphene 2maltodextrin 1licogliflozin 1bicalutamide 1Yoga 1Topiramate 1Thioctic Acid 1Sodium Salicylate 1Phlebotomy 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1Glycoprotein Hormones, alpha Subunit 1Estrogens 1Doxycycline 1Dexamethasone 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperandrogenism × Phlebotomy × Clear all
NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase NA Completed
37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡